MARKET

PTN

PTN

Palatin Tech
NASDAQ
8.55
-0.05
-0.58%
After Hours: 8.54 -0.01 -0.12% 16:03 10/12 EDT
OPEN
8.55
PREV CLOSE
8.60
HIGH
8.80
LOW
8.20
VOLUME
16.99K
TURNOVER
--
52 WEEK HIGH
31.00
52 WEEK LOW
5.61
MARKET CAP
15.23M
P/E (TTM)
-2.8853
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PTN last week (1005-1009)?
Weekly Report · 11h ago
Weekly Report: what happened at PTN last week (0928-1002)?
Weekly Report · 10/05 09:41
Palatin Technologies Earnings Call: Science vs. Cash
TipRanks · 09/30 00:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 09/28 12:05
Palatin Technologies GAAP EPS of -$1.11, revenue of $0.3M
Seeking Alpha · 09/28 12:04
Gold Fields, Harmony Gold Mining, Anglogold Ashanti And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Benzinga · 09/28 12:01
Palatin Techs Q4 EPS $(1.11) Up From $(2.73) YoY, Sales $300.770K
Benzinga · 09/28 11:39
*Palatin Doesn't Expect Existing Cash and Cash Equivalents to Be Sufficient to Fund Ops for at Least 12 Mos >PTN
Dow Jones · 09/28 11:36
More
About PTN
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. The MCR system has effects on inflammation and immune system response, food intake, metabolism, and sexual function. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. Its product development activities focus primarily on the use of MC4R agonists for treatment of obesity. It develops MC4R peptides and small molecule agonists with potential utility in obesity and metabolic-related disorders, rare MC4R pathway diseases, such as hypothalamic obesity, and orphan indications. It also develops MC1R agonist products to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease.

Webull offers Palatin Technologies Inc stock information, including NASDAQ: PTN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTN stock methods without spending real money on the virtual paper trading platform.